Merit Financial Group’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,154
| Closed | -$256K | – | 911 |
|
|
2024
Q2 | $256K | Sell |
2,154
-832
| -28% | -$98.8K | 0.01% | 768 |
|
|
2024
Q1 | $373K | Sell |
2,986
-355
| -11% | -$44.4K | 0.01% | 633 |
|
|
2023
Q4 | $332K | Sell |
3,341
-789
| -19% | -$78.5K | 0.01% | 594 |
|
|
2023
Q3 | $427K | Buy |
4,130
+93
| +2% | +$9.61K | 0.01% | 486 |
|
|
2023
Q2 | $490K | Buy |
4,037
+1,282
| +47% | +$156K | 0.02% | 472 |
|
|
2023
Q1 | $423K | Sell |
2,755
-9,924
| -78% | -$1.52M | 0.02% | 437 |
|
|
2022
Q4 | $2.28M | Sell |
12,679
-292
| -2% | -$52.4K | 0.08% | 175 |
|
|
2022
Q3 | $1.53M | Sell |
12,971
-2,831
| -18% | -$335K | 0.07% | 190 |
|
|
2022
Q2 | $2.26M | Buy |
15,802
+13,711
| +656% | +$1.96M | 0.07% | 169 |
|
|
2022
Q1 | $360K | Buy |
2,091
+791
| +61% | +$136K | 0.02% | 277 |
|
|
2021
Q4 | $330K | Buy |
1,300
+170
| +15% | +$43.2K | 0.03% | 210 |
|
|
2021
Q3 | $435K | Buy |
1,130
+185
| +20% | +$71.2K | 0.05% | 172 |
|
|
2021
Q2 | $222K | Buy |
+945
| New | +$222K | 0.02% | 246 |
|